Otsuka Holdings Co., Ltd. (FRA:OS1)

Market Cap	32.62B +31.2%
Revenue (ttm)	13.41B +6.0%
Net Income	1.97B +5.8%
EPS	3.72 +8.1%
Shares Out	n/a
PE Ratio	16.54
Forward PE	n/a
Dividend	0.79 (1.33%)
Ex-Dividend Date	Dec 29, 2025

Volume	n/a
Average Volume	2
Open	60.00
Previous Close	59.00
Day's Range	59.50 - 60.00
52-Week Range	37.60 - 61.00
Beta	n/a
RSI	62.75
Earnings Date	Apr 28, 2026

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 37,758
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OS1

Financial Performance

In 2025, Otsuka Holdings's revenue was 2.47 trillion, an increase of 5.97% compared to the previous year's 2.33 trillion. Earnings were 363.15 billion, an increase of 5.84%.

Financial numbers in JPY